Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of clinical microbiology|
|State||Published - Mar 2011|
ASJC Scopus subject areas
- Microbiology (medical)